Nephros

Nephros is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. The company ultrafilters used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters also used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. The company was founded in 1997 and is based in South Orange, New Jersey, United States.

Judy Krandel

CFO

2 past transactions

GenArraytion

Acquisition in 2021
GenArraytion Inc. is a veteran-owned small business offering products and services for medical diagnostics, including tick- and mosquito-borne disease and surveillance, epidemiology and source tracking, food and water testing, biodefense and environmental monitoring. Our MultiFLEX Bioassays and Sniper Sequencing genotyping services provide rapid, specific infectious disease assays that can improve infection disease response and treatment. GenArraytion has developed real-time multiplexed real-time PCR assays, multiplexed bead-based assays and custom microarrays for simultaneous detection of multiple pathogens and antimicrobial characterization of clinically relevant pathogens. GenArraytion is actively registered in the CCR database and is ORCA certified.

Biocon

Acquisition in 2019
Biocon Biologics Limited, based in Bengaluru, India, is a subsidiary of Biocon Limited and specializes in the development and manufacturing of biosimilars and novel biologics. Founded in 2016, the company focuses on creating high-quality, affordable biosimilars to enhance patient access to advanced therapies globally. Its product portfolio includes recombinant human insulin, insulin analogs, monoclonal antibodies, and therapeutic proteins aimed at treating various conditions such as diabetes, cancer, and autoimmune diseases. Biocon Biologics operates in multiple markets, including India, the U.S., and Europe, and is committed to the humanitarian responsibility of providing essential drugs through innovative solutions. The company also engages in contract research and manufacturing services through its subsidiary, Syngene, further strengthening its position in the biopharmaceutical sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.